Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $38.60 $44.37 Friday, 10th May 2024 XENE stock ended at $40.54. This is 4.59% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.26% from a day low at $38.60 to a day high of $42.56.
90 days $38.60 $50.99
52 weeks $27.99 $50.99

Historical Xenon Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Oct 05, 2023 $33.54 $35.42 $33.25 $35.17 696 097
Oct 04, 2023 $33.59 $33.97 $32.72 $33.50 352 085
Oct 03, 2023 $32.78 $33.75 $32.65 $33.58 377 829
Oct 02, 2023 $34.43 $34.62 $33.05 $33.06 380 754
Sep 29, 2023 $35.41 $36.21 $34.09 $34.16 487 950
Sep 28, 2023 $35.13 $35.48 $33.93 $35.33 586 668
Sep 27, 2023 $35.13 $35.55 $34.82 $35.10 1 590 148
Sep 26, 2023 $35.41 $35.84 $34.70 $35.03 398 627
Sep 25, 2023 $35.01 $35.78 $34.78 $35.31 370 167
Sep 22, 2023 $35.76 $36.03 $35.05 $35.17 264 752
Sep 21, 2023 $35.64 $36.60 $34.88 $35.76 527 083
Sep 20, 2023 $36.95 $37.89 $35.79 $35.84 307 401
Sep 19, 2023 $36.96 $37.26 $36.59 $36.72 330 716
Sep 18, 2023 $36.80 $36.92 $36.02 $36.84 279 497
Sep 15, 2023 $36.88 $37.55 $36.34 $36.86 337 073
Sep 14, 2023 $36.98 $37.71 $36.65 $36.68 540 867
Sep 13, 2023 $37.54 $37.86 $36.73 $36.96 330 278
Sep 12, 2023 $37.37 $37.85 $37.26 $37.27 189 850
Sep 11, 2023 $38.18 $38.18 $37.33 $37.38 257 600
Sep 08, 2023 $38.82 $39.00 $37.94 $38.14 209 447
Sep 07, 2023 $38.90 $39.38 $38.64 $38.68 299 950
Sep 06, 2023 $39.52 $39.60 $38.41 $39.09 191 658
Sep 05, 2023 $39.75 $39.96 $38.90 $39.31 267 037
Sep 01, 2023 $39.24 $40.14 $39.09 $39.73 211 052
Aug 31, 2023 $38.99 $39.27 $38.48 $38.98 385 423
Click to get the best stock tips daily for free!

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals. Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment o... XENE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT